• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病是轻度认知障碍患者向痴呆转化的独立危险因素。

Type 2 diabetes is an independent risk factor for dementia conversion in patients with mild cognitive impairment.

机构信息

Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain; CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Spain.

Fundació ACE, Barcelona Alzheimer Treatment & Research Center, Barcelona, Spain.

出版信息

J Diabetes Complications. 2017 Aug;31(8):1272-1274. doi: 10.1016/j.jdiacomp.2017.04.018. Epub 2017 Apr 19.

DOI:10.1016/j.jdiacomp.2017.04.018
PMID:28545893
Abstract

AIMS

To explore whether type 2 diabetes (T2D) is a risk factor for dementia conversion in patients with mild cognitive impairment (MCI).

METHODS

A longitudinal nested case-control study in which 101 T2D patients and 101 non-diabetic patients with MCI matched by age and gender were included.

RESULTS

The dementia conversion rate was 57.4% in T2D patients vs. 42.6% in non-diabetic subjects (p=0.02). T2D and APOE ε4 allele were independent risk factors for developing dementia.

CONCLUSION

T2D is an independent risk factor for dementia conversion in MCI patients. This finding has significant clinical implications.

摘要

目的

探讨 2 型糖尿病(T2D)是否是轻度认知障碍(MCI)患者发生痴呆转化的危险因素。

方法

这是一项纵向巢式病例对照研究,纳入了 101 例 T2D 患者和 101 例年龄和性别相匹配的非糖尿病 MCI 患者。

结果

T2D 患者的痴呆转化率为 57.4%,而非糖尿病患者为 42.6%(p=0.02)。T2D 和 APOE ε4 等位基因是发生痴呆的独立危险因素。

结论

T2D 是 MCI 患者痴呆转化的独立危险因素。这一发现具有重要的临床意义。

相似文献

1
Type 2 diabetes is an independent risk factor for dementia conversion in patients with mild cognitive impairment.2 型糖尿病是轻度认知障碍患者向痴呆转化的独立危险因素。
J Diabetes Complications. 2017 Aug;31(8):1272-1274. doi: 10.1016/j.jdiacomp.2017.04.018. Epub 2017 Apr 19.
2
Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.载脂蛋白E基因型和脑血管改变会影响轻度认知障碍患者向痴呆症的转变。
J Alzheimers Dis. 2014;41(2):401-10. doi: 10.3233/JAD-132480.
3
Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.2 型糖尿病患者轻度认知障碍早期诊断的生物标志物:一项多中心、回顾性、巢式病例对照研究。
EBioMedicine. 2016 Feb 6;5:105-13. doi: 10.1016/j.ebiom.2016.02.014. eCollection 2016 Mar.
4
Conversion of mild cognitive impairment to dementia among subjects with diabetes: a population-based study of incidence and risk factors with five years of follow-up.糖尿病患者中轻度认知障碍向痴呆症的转变:一项基于人群的发病率和危险因素的五年随访研究。
J Alzheimers Dis. 2015;43(4):1441-9. doi: 10.3233/JAD-141566.
5
Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study.载脂蛋白 E 基因型是否是轻度认知障碍的生物标志物?一项全国代表性研究的结果。
Neuropsychology. 2011 Nov;25(6):679-89. doi: 10.1037/a0024483.
6
Risk factors for development of dementia in a unique six-year cohort study. I. An exploratory, pilot study of involvement of the E4 allele of apolipoprotein E, mutations of the hemochromatosis-HFE gene, type 2 diabetes, and stroke.在一项独特的六年队列研究中痴呆发展的风险因素。I. 载脂蛋白 E 的 E4 等位基因、血色病-HFE 基因突变、2 型糖尿病和中风参与的探索性、初步研究。
J Alzheimers Dis. 2014;38(4):907-22. doi: 10.3233/JAD-131409.
7
Accelerated progression from mild cognitive impairment to dementia among APOE ε4ε4 carriers.载脂蛋白 E ε4ε4 携带者从中度认知障碍向痴呆的加速进展。
J Alzheimers Dis. 2013;33(2):507-15. doi: 10.3233/JAD-2012-121369.
8
Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.载脂蛋白 E ɛ4 等位基因对从 MCI 向 AD 型痴呆进展的预测价值:一项荟萃分析。
J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1149-56. doi: 10.1136/jnnp.2010.231555. Epub 2011 Apr 14.
9
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.阿尔茨海默病全基因组显著风险因素:在轻度认知障碍患者进展为阿尔茨海默病所致痴呆中的作用。
Mol Psychiatry. 2017 Jan;22(1):153-160. doi: 10.1038/mp.2016.18. Epub 2016 Mar 15.
10
Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.在阿尔茨海默病患者中,与从轻度认知障碍向痴呆快速进展相关的是损伤标志物,而不是淀粉样蛋白标志物。
J Alzheimers Dis. 2012;29(2):319-27. doi: 10.3233/JAD-2011-111694.

引用本文的文献

1
A prediction nomogram for mild cognitive impairment in type 2 diabetes mellitus based on the Chinese visceral adiposity index.基于中国内脏脂肪指数的2型糖尿病轻度认知障碍预测列线图。
Sci Rep. 2025 Sep 9;15(1):32393. doi: 10.1038/s41598-025-17241-5.
2
Genetic mechanisms of dynamic functional connectivity density in diabetic retinopathy brains: a combined transcriptomic and resting-state functional magnetic resonance imaging study.糖尿病视网膜病变患者大脑中动态功能连接密度的遗传机制:一项转录组学与静息态功能磁共振成像的联合研究
Front Cell Neurosci. 2025 Apr 10;19:1476038. doi: 10.3389/fncel.2025.1476038. eCollection 2025.
3
The Diabetic Cognitive Impairment Score for Early Screening of Cognitive Impairment in Type 2 Diabetes Patients.
用于2型糖尿病患者认知障碍早期筛查的糖尿病认知障碍评分
J Diabetes Res. 2025 Apr 16;2025:8029913. doi: 10.1155/jdr/8029913. eCollection 2025.
4
Risk Prediction Models for Mild Cognitive Impairment in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.2型糖尿病患者轻度认知障碍的风险预测模型:系统评价与Meta分析
Diabetes Metab Syndr Obes. 2024 Nov 25;17:4425-4438. doi: 10.2147/DMSO.S489819. eCollection 2024.
5
Effect of hypoglycemic events on cognitive function in individuals with type 2 diabetes mellitus: a dose-response meta-analysis.低血糖事件对2型糖尿病患者认知功能的影响:一项剂量反应荟萃分析。
Front Neurol. 2024 Aug 13;15:1394499. doi: 10.3389/fneur.2024.1394499. eCollection 2024.
6
Diabetes mellitus and risk of incident dementia in APOE ɛ4 carriers: an updated meta-analysis.糖尿病与载脂蛋白 E4 携带者发生痴呆的风险:一项更新的荟萃分析。
BMC Neurosci. 2024 Jun 25;25(1):28. doi: 10.1186/s12868-024-00878-9.
7
Functional connectivity density aberrance in type 2 diabetes mellitus with and without mild cognitive impairment.伴或不伴轻度认知障碍的2型糖尿病患者的功能连接密度异常
Front Neurol. 2024 Jun 10;15:1418714. doi: 10.3389/fneur.2024.1418714. eCollection 2024.
8
Oral phytate supplementation on the progression of mild cognitive impairment, brain iron deposition and diabetic retinopathy in patients with type 2 diabetes: a concept paper for a randomized double blind placebo controlled trial (the PHYND trial).口服植酸盐对 2 型糖尿病患者轻度认知障碍、脑铁沉积和糖尿病视网膜病变进展的影响:一项随机双盲安慰剂对照试验的概念性研究(PHYND 试验)。
Front Endocrinol (Lausanne). 2024 May 30;15:1332237. doi: 10.3389/fendo.2024.1332237. eCollection 2024.
9
A new nomogram model for the individualized prediction of mild cognitive impairment in elderly patients with type 2 diabetes mellitus.一种用于个体化预测老年2型糖尿病患者轻度认知障碍的新列线图模型。
Front Endocrinol (Lausanne). 2024 Apr 9;15:1307837. doi: 10.3389/fendo.2024.1307837. eCollection 2024.
10
Association of hypoglycemic events with cognitive impairment in patients with type 2 diabetes mellitus: Protocol for a dose-response meta-analysis.2 型糖尿病患者低血糖事件与认知障碍的关联:剂量反应荟萃分析方案。
PLoS One. 2024 Feb 2;19(2):e0296662. doi: 10.1371/journal.pone.0296662. eCollection 2024.